Multiplexing Prism for Monocular Vision
Trial Summary
What is the purpose of this trial?
The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators are testing a simplified design and fitting protocol to provide field expansion for individuals with acquired monocular vision.
Research Team
Eli Peli, OD
Principal Investigator
Schepens Eye Research Institute
Eligibility Criteria
This trial is for people who have lost vision in one eye for more than a year, but still have good vision (better than 20/32) in their other eye without any field defects. They should not have health issues like seizures or motor movement problems.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are fitted with the multiplexing prism to expand the field of view
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Multiplexing Prism
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts Eye and Ear Infirmary
Lead Sponsor
National Eye Institute (NEI)
Collaborator